
Sperazole 40 Injection
Marketer
Affy Pharma Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Sperazole 40 Injection
Gastric acid production is suppressed by the intravenous medication, Acidol 40 Injection. This proton pump inhibitor (PPI) treats stomach and intestinal disorders stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It alleviates symptoms and aids healing. Acidol 40 Injection also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Administered intravenously by a healthcare provider, this injection is reserved for patients where oral medication is deemed unsuitable. Dosage and treatment duration are determined by your physician based on individual needs and response. Consistent use, as prescribed, is crucial, even with rapid symptom improvement. Dietary modifications, such as frequent small meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment efficacy. Common, typically mild, side effects may include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects necessitate medical consultation. Prolonged use (over one year) may elevate the risk of bone fractures, particularly at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. Acidol 40 Injection is contraindicated for individuals with severe liver impairment, those taking HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Uses of Sperazole 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Sperazole 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Sperazole 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Sperazole 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Sperazole 40 Injection works:
Stomach acid is neutralized by the proton pump inhibitor Sperazole 40 Injection, thereby alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sperazole 40 Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Sperazole 40 Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Sperazole 40 Injection safely. Available human data indicates minimal infant risk associated with the medication.
DrivingCONSULT YOUR DOCTOR
The effect of Sperazole 40 Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The administration of Sperazole 40 Injection is considered safe for individuals with renal impairment. No alteration of the Sperazole 40 Injection dosage is necessary.
LiverCAUTION
The use of Sperazole 40 Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification for Sperazole 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Sperazole 40 Injection :
Omit a Sperazole 40 Injection dose? Seek your physician's advice.
Facts to Know About Sperazole 40 Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfoxide compound |
| Addictive | None. |
| Medication Category | Digestive system |
| Mechanism of Action | Gastric acid secretion suppressants |
